BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Figueira J, Henriques J, Carneiro Â, Marques-Neves C, Flores R, Castro-Sousa JP, Meireles A, Gomes N, Nascimento J, Amaro M, Silva R. Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization. Clin Ophthalmol 2021;15:3221-30. [PMID: 34354341 DOI: 10.2147/OPTH.S318026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Patil NS, Mihalache A, Hatamnejad A, Popovic MM, Kertes PJ, Muni RH. Intravitreal steroids compared to anti-vascular endothelial growth factor treatment for diabetic macular edema: a meta-analysis. Ophthalmology Retina 2022. [DOI: 10.1016/j.oret.2022.10.008] [Reference Citation Analysis]
2 Zhang Y, Xu F, Lin Z, Wang J, Huang C, Wei M, Zhai W, Li J, Sasaoka T. Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning. Journal of Diabetes Research 2022;2022:1-10. [DOI: 10.1155/2022/5779210] [Reference Citation Analysis]
3 Lin W, Feng M, Liu T, Wang Q, Wang W, Xie X, Li W, Guan J, Ma Z, Liu T, Zhou Q. Microvascular Changes After Conbercept Intravitreal Injection of PDR With or Without Center-Involved Diabetic Macular Edema Analyzed by OCTA. Front Med 2022;9:797087. [DOI: 10.3389/fmed.2022.797087] [Reference Citation Analysis]
4 Santos FM, Mesquita J, Castro-de-sousa JP, Ciordia S, Paradela A, Tomaz CT. Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases. Antioxidants 2022;11:505. [DOI: 10.3390/antiox11030505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]